Effects of Naproxen on Cell Proliferation and Genotoxicity in MG-63 Osteosarcoma Cell Line

REFERENCES

• Arantes-Rodrigues, R., Pinto-Leite, R., Fidalgo-Gonçalves, L., Gaivão, I., Colaço, A., Oliveira, P., and Santos, L., 2013a. Meloxicam synergistically enhances the in vitro effects of sunitinib malate on bladder-cancer cells. J. Appl. Biomed. 11: 79–92.
   Web of Science ®Google Scholar
• Arantes-Rodrigues, R., Pinto-Leite, R., Ferreira, R., Neuparth, M. J., Pires, M. J., Gaivão, I., Palmeira, C., Santos, L., Colaço, A., and Oliveira, P. 2013b. Meloxicam in the treatment of in vitro and in vivo models of urinary bladder cancer. Biomed. Pharmacother. 67: 277–284.
   PubMed Web of Science ®Google Scholar
• Collins, A. R., Oscoz, A. A., Brunborg, G., Gaivão, I., Giovannelli, L., Kruszewski, M., Smith, C. C., and Stetina, R. 2008. The comet assay: Topical issues. Mutagenesis 23: 143–151.
   PubMed Web of Science ®Google Scholar
• De Luna-Bertos, E., Ramos-Torrecillas, J., García-Martínez, O., Díaz-Rodríguez, L., and Ruiz, C. 2012. Effect of aspirin on cell growth of human MG-63 osteosarcoma line. Sci. World J. 2012: 834246.
   Google Scholar
• Díaz-Rodríguez, L., García-Martínez, O., Arroyo-Morales, M., Rubio-Ruiz, B., and Ruiz, C. 2010. Effect of acetaminophen (paracetamol) on human osteosarcoma cell line MG63. Acta Pharmacol. Sin. 31: 1495–1499.
   PubMed Web of Science ®Google Scholar
• Elmore, E., Steele, V. E., and Redpath, J. L. 2010. Evaluation of the effects of naproxen in human colon polyp cells using gene expression and pathways analysis. Cancer Prev. Res. 3: 1158–1940.
   Google Scholar
• Evans, C. E., and Butcher, C. 2004. The influence on human osteoblasts in vitro of non-steroidal anti-inflammatory drugs which act on different cyclooxygenase enzymes. J. Bone Joint Surg. Br. 86: 444–449.
   PubMed Web of Science ®Google Scholar
• Ferguson, W. S., and Goorin, A. M. 2001. Current treatment of osteosarcoma. Cancer Invest. 19: 292–315.
   PubMed Web of Science ®Google Scholar
• Heymann, D., and Rédini, F. 2013. Targeted therapies for bone sarcomas. BoneKey Rep. doi:10.1038/bonekey.2013.112.
   Google Scholar
• Kaspar, D., Hedrich, C. M., Schmidt, C., Liedert, A., Claes, L. E., and Ignatus, A. A. 2005. Diclofenac inhibits proliferation and matrix formation of osteoblast cells. Unfallchirurg 108: 20–44.
   Google Scholar
• Khan, K. N. M., Masferrer, J. L., Soslow, R., and Koki, A. T. 2001. Enhanced cyclooxygenase-2 expression in sporadic and familial adenomatous polyposis of the human colon. Scand. J. Gastroenterol. 36: 865–869.
   PubMed Web of Science ®Google Scholar
• Liu, B., Shi, Z. L., Feng, J., and Tao, H. M. 2008. Celecoxib, a cyclooxygenase-2 inhibitor, induces apoptosis in human osteosarcoma cell line MG-63 via down-regulation of PI3K/Akt. Cell Biol. Int. 32: 494–501.
   PubMed Web of Science ®Google Scholar
• Luo, X., Chen, J., Song, W., Tang, N., Luo, J., Deng, Z., and Sharff, K. A. 2008. Osteogenic BMPs promote tumor growth of human osteosarcomas that harbor differentiation defects. Lab. Invest. 88: 1264–1277.
   PubMed Web of Science ®Google Scholar
• Moalic, S., Liagre, B., Le Bail, J. C., and Beneytout, J. L. 2001. Dose-dependent modulation of apoptosis and cyclooxygenase-2 expression in human 1547 osteosarcoma cells by NS-398, a selective cyclooxygenase-2 inhibitor. Int. J. Oncol. 18: 533–540.
   PubMed Web of Science ®Google Scholar
• Naruse, T., Nishida, Y., and Hosono, K. 2006. Meloxicam inhibits osteosarcoma growth, invasiveness and metastasis by COX-2-dependent and independent routes. Carcinogenesis 27: 584–592.
   PubMed Web of Science ®Google Scholar
• Pinto-Leite, R., Arantes-Rodrigues, R., Palmeira, C., Colaço, B., Lopes, C., Colaço, A., Costa, C., da Silva, V. M., Oliveira, P., and Santos, L. 2013. Everolimus combined with cisplatin has a potential role in treatment of urothelial bladder cancer. Biomed. Pharmacother. 67: 116–121.
   PubMed Web of Science ®Google Scholar
• Pirhonen, J., and Pulkkinen, M. 1995. The effect of nimesulide and naproxen on the uterine and ovarian arterial blood flow velocity. A Doppler study. Acta Obstet. Gynecol. Scand. 74: 549–553.
   PubMed Web of Science ®Google Scholar
• Sadikovic, B., Thorner, P., Chilton-MacNeill, S., Martin, J. W., Cervigne, N. K., Squire, J., and Zielenska, M. 2010. Expression analysis of genes associated with human osteosarcoma tumors shows correlation of RUNX2 overexpression with poor response to chemotherapy. BMC Cancer 10:202.
   Google Scholar
• Siclari, V. A., and Qin, L. 2010. Targeting the osteosarcoma cancer stem cell. J. Orthoped. Surg. Res. 5: 78.
   Google Scholar
• Sobolewski, C., Cerella, C., Dicato, M., Ghibelli, L., and Diederich, M. 2010. The role of cyclooxygenase-2 in cell proliferation and cell death in human malignancies. Int. J. Cell Biol. 2010: 215158.
   Google Scholar
• Thompson, L., Wang, S., Tawfik, O., Templeton, K., Tancabelic, J., and Pinson, D. 2011. Effect of 25-hydroxyvitamin D3 and 1 α,25 dihydroxyvitamin D3 on differentiation and apoptosis of human osteosarcoma cell lines. J. Orthoped. Res. 30: 831–844.
   PubMed Web of Science ®Google Scholar
• Tseng, S. H., Chen, S. C., Wu, C. H., and Wang, C. C. 2005. Anti-proliferative effects of NSAIDs on MG-63 osteoblasts-like cells. J. Chin. Oncol. Soc. 21: 7–15.
   Google Scholar
• Xu, Z., Choudhary, S., Voznesensky, O., Mehrotra, M., Woodard, M., Hansen, M., Herschman, H., and Pilbeam, C. 2006. Overexpression of COX-2 in human osteosarcoma cells decreases proliferation and increases apoptosis. Cancer Res 66: 6657–6664.
   PubMed Web of Science ®Google Scholar